Daewoong's Erdos confirmed its COPD effects.

Published: 2006-04-14 06:57:00

Updated: 2006-04-14 06:57:00

In the Spring conference of the Korea Society of TB and Repiratory Tracts at Daeduk Convention Center in Daejon city, Daewoong took a symposium on the title of "Anti-oxidant effects of Erdos (erdosteine).

Prof. Negro, the University of Milan, who is reputed with the respiratory diseases said ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK